13-51958361-TG-TGG

Variant summary

Our verdict is Pathogenic.
>+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 18 classification points (ACMG Germline Pathogenicity v2019). PVS1PS3PM2PP5_Strong

The NM_000053.4(ATP7B):c.2304dupC (p.Met769HisfsTer26) variant causes a frameshift change. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The variant allele was found at a cumulative frequency of 0.0000979 (AC=158) in the gnomAD database across 1,614,022 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000112. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000694419: One functional study showed more than 50% decrease in ATPase activity in lymphoblasts a WD homozygote patient (Shah_AJHG_1997)." and additional evidence is available in ClinVar.

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000096 ( 0 hom. )

Consequence

ATP7B
NM_000053.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:29O:1

Conservation

PhyloP100: -2.18

Publications

1 publications found
Variant links:
Genes affected
ATP7B (HGNC:870): (ATPase copper transporting beta) This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019]
ATP7B Gene-Disease associations (from GenCC):
  • Wilson disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Natera, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000053.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 18 points.

PVS1Null variant in LOF gene
Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Frameshift (exon 8 of 21) at amino acid 768 of 1465, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene. A new stop codon is introduced in the shifted frame, truncating the protein to ~793 amino acids (672 amino acids lost).
PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000694419: One functional study showed more than 50% decrease in ATPase activity in lymphoblasts a WD homozygote patient (Shah_AJHG_1997).; SCV004845542: "Lymphoblast cells derived from an individual homozygous for this variant showed loss of copper-stimulated ATPase activity (PMID: 9311736)."; SCV005061166: An experimental study showed this variant caused a more than 50% decrease in ATPase activity in lymphoblasts in a homozygote patient affected with Wilson disease (Shah et al., 1997).
PM2Absent/extremely low in population databases
Very rare in gnomAD for AR/unknown gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.000112 — very rare for AR gene (base 0.001, raised to 0.00322 by highest known P/LP ClinVar AF 0.00322) — PM2 moderate.
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (29/29 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000053.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ATP7B NM_000053.4
MANE Select
HGVSc / HGVSpc.2304dupCp.Met769HisfsTer26
Exon rankExon 8 of 21
frameshift
Prot: NP_000044.2UniProt: P35670-1
ATP7B NM_001406511.1
HGVSc / HGVSpc.2304dupCp.Met769HisfsTer26
Exon rankExon 9 of 22
frameshift
Prot: NP_001393440.1UniProt: P35670-1
ATP7B NM_001406512.1
HGVSc / HGVSpc.2304dupCp.Met769HisfsTer26
Exon rankExon 9 of 22
frameshift
Prot: NP_001393441.1UniProt: P35670-1

Ensembl Transcripts

ATP7B ENST00000242839.10
TSL:1MANE Select
HGVSc / HGVSpc.2304dupCp.Met769HisfsTer26
Exon rankExon 8 of 21
frameshift
Prot: ENSP00000242839.5UniProt: P35670-1
ATP7B ENST00000634844.1
TSL:1
HGVSc / HGVSpc.2160dupCp.Met721HisfsTer26
Exon rankExon 8 of 21
frameshift
Prot: ENSP00000489398.1UniProt: A0ACI8PQU0
ATP7B ENST00000418097.7
TSL:1
HGVSc / HGVSpc.2304dupCp.Met769HisfsTer26
Exon rankExon 8 of 20
frameshift
Prot: ENSP00000393343.2UniProt: F5H748

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.000118
AC:18
Hom:0
AN:152130
Cov:32
GnomAD2 exomes
AF: 0.000108
AC:27
AN:249552
GnomAD4 exome
AF: 0.0000958
AC:140
Hom:0
AN:1461892
Cov:31
GnomAD4 genome
AF: 0.000118
AC:18
Hom:0
AN:152130
Cov:32
TOPMed (Bravo)
AF: 0.0000945
AC:25
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000990
AC:3
Hom:0
AN:30296
Local & regional cohorts 3 sources
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0000490
AC:6
Hom:0
AN:122696
Turkish Variome
AF: 0.000708
AC:4
Hom:0
AN:5176
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.00
AC:0
Hom:0
AN:8960
Showing 9 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.000104 *19622 0.0000959 *110428
BipEx
(Bipolar disorder (including schizoaffective))
0.000106 328420 0.0000693 228844
Epi25
(Epilepsy)
0.0000953 441958 0.000105 766888
SCHEMA
(Schizophrenia)
0.000205 25121906 0.000110 21190632
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
22
-
-
Wilson disease (23)
5
-
-
not provided (5)
1
-
-
ATP7B-related disorder (1)
1
-
-
Inborn genetic diseases (1)

Computational Scores

Mutation Taster
N/A0/200disease causing (ClinVar)
PhyloP100
Benign-2.2
Showing 2 of 2 scores

Splicing Scores

SpliceAI score (max)
Benign0.020
Details are displayed if max score is > 0.2
Showing 1 of 1 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs137853287;
hg19: chr13-52532497;
COSMIC: COSV54435797;
COSMIC: COSV54435797;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.